BiomX Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BiomX Inc. (PHGE) on January 13, 2026, regarding events occurring on that date. The company, incorporated in Delaware and headquartered in Ness Ziona, Israel, reported the consummation of a previously announced private placement and associated corporate governance changes.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial event reported is the issuance of 3,300 shares of Series Y Convertible Preferred Stock and warrants to purchase common stock as part of the private placement closing.
Material Changes
- Private Placement Closing: The company consummated a private placement pursuant to a Securities Purchase Agreement dated December 26, 2025.
- Board Expansion: The Board of Directors increased its size to nine members.
- New Director Appointment: Mr. Reuven Yeganeh was appointed as a Class 1 director, effective January 13, 2026, for a term ending in 2027. His appointment is contingent on the Lead Buyer beneficially owning at least 9.99% of the company's common stock on an as-converted basis.
- Corporate Governance: The company filed a Certificate of Designations for the Series Y Convertible Preferred Stock with the Delaware Secretary of State.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or specific risk factors beyond the standard contingencies associated with the private placement terms. Mr. Yeganeh's board seat is subject to the ownership threshold condition noted above. An indemnification agreement was executed with Mr. Yeganeh on standard terms.
Key Facts for Investor Verification
- Verify the total capital raised and specific terms of the Series Y Convertible Preferred Stock and warrants in the December 29, 2025 Current Report (referenced in this filing).
- Confirm the Lead Buyer's current beneficial ownership percentage to ensure Mr. Yeganeh's directorship remains valid.
- Review the full text of the Certificate of Designations (Exhibit 3.1 to the December 29, 2025 filing) for conversion rates, liquidation preferences, and voting rights of the new preferred stock.
- Assess the impact of the new board composition on future strategic direction, given Mr. Yeganeh's background in investment management and cannabis/real estate sectors.